The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and
Device Transactions Medtech fundraising totaled $714 million in 2014’s opening quarter, a significant decrease – just over 40% – from Q4 2013’s $1.2 billion. ( See Exhibit 1. ) Exhibit 1 Q1 2014 Devic
IN VITRO DIAGNOSTICS Mergers & Acquisitions Roche Roche Molecular Diagnostics IQuum Inc. Roche paid $275mm up front for private molecular diagnostics company IQuum Inc. , which is also eligible